Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the presence of Philadelphia translocation t(9;22)(q34;q11), resulting in the expression of a constitutively active BCR-ABL kinase. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.